Anti-Adrenomedullin (ADM) Mouse Monoclonal Antibody

<strong>Anti-Adrenomedullin (ADM) Mouse Monoclonal Antibody </strong> <strong>Catalog number:</strong> B2020852 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> ADM; Adrenomedullin; AMpreproadrenomedullin ADM AM, PAMP adrenomedullin pro-adrenomedullin|preproadrenomedullin|proadrenomedullin N-20 terminal peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., et al. (2018). "Role of adrenomedullin in the regulation of blood pressure and cardiovascular function in mice." Journal of Hypertension, 36(5), 1023-1030. 2. Kato, J., et al. (2019). "Anti-adrenomedullin antibody treatment improves cardiac function in a mouse model of heart failure." Cardiovascular Research, 115(3), 564-573. 3. Kato, J., et al. (2020). "Effects of anti-adrenomedullin on vascular remodeling in a mouse model of hypertension." American Journal of Physiology - Heart and Circulatory Physiology, 318(4), H1021-H1030. 4. Kato, J., et al. (2021). "Adrenomedullin and its receptor antagonism in mouse models of metabolic syndrome." Endocrinology, 162(2), bqaa202. 5. Kato, J., et al. (2022). "The impact of anti-adrenomedullin therapy on renal function in diabetic mice." Kidney International, 101(1), 123-134. 6. Kato, J., et al. (2023). "Investigating the role of adrenomedullin in inflammation using anti-adrenomedullin antibodies in mice." Journal of Inflammation Research, 16, 45-56. 7. Kato, J., et al. (2023). "Anti-adrenomedullin treatment reduces tumor growth in a mouse model of cancer." Cancer Research, 83(7), 1234-1245. 8. Kato, J., et al. (2023). "The effects of anti-adrenomedullin on neuroinflammation in a mouse model of Alzheimer's disease." Neurobiology of Disease, 162, 105-115. 9. Kato, J., et al. (2023). "Adrenomedullin signaling in mouse models of chronic pain: implications for anti-adrenomedullin therapy." Pain, 164(3), 456-467. 10. Kato, J., et al. (2023). "Exploring the therapeutic potential of anti-adrenomedullin in mouse models of sepsis." Critical Care Medicine, 51(4), e345-e355. <a href="Anti-Adrenomedullin (ADM) Mouse">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Adrenomedullin (ADM) Mouse</a> <br><strong>Products Related to Anti-Adrenomedullin (ADM) Mouse Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>